Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600381's Days Inventory is ranked worse than 83.62% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.58
vs SHSE:600381: 298.14
Inventory Turnover measures how fast the company turns over its inventory within a year.
Qinghai Spring Medicinal Resources Technology Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.18.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Qinghai Spring Medicinal Resources Technology Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 3.45.
Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Qinghai Spring Medicinal Resources Technology Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Qinghai Spring Medicinal Resources Technology Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Qinghai Spring Medicinal Resources Technology Co Days Inventory Related Terms
Qinghai Spring Medicinal Resources Technology Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qinghai Spring Medicinal Resources Technology Co Days Inventory Chart
Qinghai Spring Medicinal Resources Technology Co Annual Data
SHSE:600381 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Qinghai Spring Medicinal Resources Technology Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qinghai Spring Medicinal Resources Technology Co Days Inventory vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) has a Days Inventory of 499.08 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Qinghai Spring Medicinal Resources Technology Co and its competitors. This is 38% below median its historical median of 809.87. Over the past decade, Qinghai Spring Medicinal Resources Technology Co's Days Inventory has ranged from 298.14 to 1,621.61. According to the industry distribution chart, Qinghai Spring Medicinal Resources Technology Co ranks #771 out of 922 companies in the Drug Manufacturers industry, placing it in the top 83.6%.
Is Qinghai Spring Medicinal Resources Technology Co's Days Inventory too high?
Qinghai Spring Medicinal Resources Technology Co's current Days Inventory of 499.08 is 38% below median its 10-year median of 809.87. Over the past 10 years, this metric has ranged from a low of 298.14 to a high of 1,621.61. The Drug Manufacturers industry median Days Inventory is 164.58. Qinghai Spring Medicinal Resources Technology Co's value of 499.08 is 203.2% above this industry median. Based on the distribution chart, Qinghai Spring Medicinal Resources Technology Co ranks #771 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Qinghai Spring Medicinal Resources Technology Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qinghai Spring Medicinal Resources Technology Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Qinghai Spring Medicinal Resources Technology Co ranks #771 out of 922 companies for Days Inventory. This places Qinghai Spring Medicinal Resources Technology Co in the lower half of its industry. The industry median Days Inventory is 164.58. Qinghai Spring Medicinal Resources Technology Co's value of 499.08 is 203.2% above this benchmark. Historically, Qinghai Spring Medicinal Resources Technology Co's own Days Inventory has ranged from 298.14 to 1,621.61 over the past decade. While the company's 10-year median is 809.87 vs. the industry median of 164.58, Qinghai Spring Medicinal Resources Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.58, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qinghai Spring Medicinal Resources Technology Co's current Days Inventory of 499.08 is 203.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Qinghai Spring Medicinal Resources Technology Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qinghai Spring Medicinal Resources Technology Co's current Days Inventory is 499.08, which is 38% below median its own 10-year median of 809.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qinghai Spring Medicinal Resources Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.85, compared to a current price of ¥4.20 — trading 28.2% below its estimated fair value. The current Days Inventory is 499.08, which is 38% below median its 10-year median of 809.87 and 203.2% above the Drug Manufacturers industry median of 164.58. Qinghai Spring Medicinal Resources Technology Co's overall GF Score™ is 68/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Qinghai Spring Medicinal Resources Technology Co (SHSE:600381), the current Days Inventory is 499.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Overvalued in 2026?
Based on GuruFocus' analysis, Qinghai Spring Medicinal Resources Technology Co stock appears to be undervalued.
The current stock price of ¥4.20 is trading 28.2% below its estimated GF Value™ of ¥5.85.
GuruFocus considers Qinghai Spring Medicinal Resources Technology Co to be Modestly Undervalued.
Key valuation signals for SHSE:600381:
Days Inventory: 499.08 (38% below median its 10-year median of 809.87)
GF Value™: ¥5.85 vs. price of ¥4.20 (28.2% below fair value)
Industry Position: 203.2% above the Drug Manufacturers median (#771 of 922)
No single metric tells the full story. See the SHSE:600381 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qinghai Spring Medicinal Resources Technology Co Business Description
Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.
68GF Score
Get the complete analysis for SHSE:600381
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600381 has been successfully added to your 
